New benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands

The present application concerns novel benzimidazole enantiomeric derivatives, their process of preparation and their therapeutical uses as dual H1 and H4 receptor ligands.

Saved in:
Bibliographic Details
Main Authors ROBERT, PHILIPPE, LECOMTE, JEANNE-MARIE, KRIEF, STEPHANE, CAPET, MARC, LIGNEAU, XAVIER, LABEEUW, OLIVIER, SCHWARTZ, JEANARLES, BILLOT, XAVIER, LEVOIN, NICOLAS, BERREBI-BERTRAND, ISABELLE, CALMELS, THIERRY
Format Patent
LanguageChinese
English
Published 16.06.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present application concerns novel benzimidazole enantiomeric derivatives, their process of preparation and their therapeutical uses as dual H1 and H4 receptor ligands.
Bibliography:Application Number: TW20187140634